High Quality Compounders — ROCE > 20% and Revenue Growth > 15% on NYSE & NASDAQ

A quality compounder is a business that earns exceptional returns on capital (ROCE above 20%) while consistently growing its revenue base (above 15% annually). The compounding effect comes from reinvesting earnings at high returns: a business earning 25% ROCE and reinvesting at that rate doubles its intrinsic value in approximately 3 years. Over 10 years, that's a 10× increase in business value driven purely by the compounding mathematics.

ROCE measures return on all capital employed — equity and debt — which is the complete pool of resources the business uses. Unlike ROE (which can be inflated by leverage), ROCE cannot be artificially enhanced by borrowing. A business with ROCE of 25% is generating genuine operational returns that reflect real competitive advantages, not financial structure choices.

The reinvestment rate and ROCE determine the growth in intrinsic value: Value Growth Rate ≈ Reinvestment Rate × ROCE. A business with 25% ROCE that reinvests 60% of operating profit grows intrinsic value at 15% annually (0.6 × 25%). Revenue growth of 15%+ confirms the reinvestment is actually creating commercial expansion — the theoretical compounding rate is being realized in real revenue.

Consistent ROCE above 20% almost always reflects one or more of: (1) Pricing power — customers pay premium prices because the product is differentiated. (2) Network effects — value increases with users, creating a barrier. (3) Switching costs — customers can't easily change providers. (4) Regulatory moats — licenses, patents, or regulated monopoly positions. (5) Cost advantages — structural production cost advantages. Identifying the specific moat source is essential for assessing durability.

The appropriate P/E depends on the ROCE and reinvestment rate. A business with 25% ROCE reinvesting 60% of earnings at that rate grows intrinsic value at 15% annually. At P/E of 25 (4% earnings yield), you need the intrinsic value growth to compensate. At P/E of 30 with 20% intrinsic value growth, the math still works over 5+ years. The key question: does the intrinsic value growth rate justify the P/E multiple being paid?

A moat (Warren Buffett's term) is a sustainable competitive advantage that protects above-average returns from competition. Identifiable signs: pricing power without losing market share, consistently high gross margins (above 40-50%), customer retention rates above 90%, renewal rates for subscriptions, brand premium in consumer surveys, and switching cost evidence (long customer contracts, high implementation costs). The ROCE above 20% sustained for 5+ years is the quantitative evidence that a moat exists.

Winner Stocks requires ROCE > 20%, ROE > 20%, revenue growth > 15%, AND earnings growth > 15% — four simultaneous criteria. High Quality Compounders requires only ROCE > 20% and revenue growth > 15%. The Compounder screen is slightly broader, capturing high-ROCE businesses with strong revenue growth even if the current year's earnings growth is below 15%. Winner Stocks is the strictest combined filter.

Rarely in normal markets — they almost always command premium valuations. However, during broad market corrections, sector-specific pessimism, or transitional uncertainty periods, even quality compounders trade at reasonable multiples. The best investment entries in quality compounders occur when market sentiment temporarily ignores fundamental quality — the Magic Formula Greenblatt methodology specifically seeks this combination.

5–10+ years to capture the full benefit of compounding. Shorter holding periods capture only the cyclical or sentiment-driven return component, missing the business value creation that compounding produces. The most successful quality compounder investors (Buffett, Fisher, Munger) characteristically hold their best positions for decades, reinvesting dividends or capital into additional quality compounders as they're identified.

They outperform over full market cycles (5+ years) but not necessarily in every year. In speculative bull markets, low-quality high-momentum stocks often outperform quality. In deep bear markets, quality compounders fall with the market due to correlated selling. Over 5-10 year periods, quality compounders with consistently high ROCE and revenue growth have historically been the best equity returners in the US market.